Skip to main content

Press Releases

Clinical, Press Releases

Researchers Identify 4 Predictors of Transition to Chronic Opioid Use Based on Readily Available Opioid Regimen and Patient Factors

Access Market Intelligence Introduces Online Glossary of Common Drug Related Terms and Acronyms as e-Book

Onco360 Announces Hiring of Bill Gittinger; National Director of Managed Care

IMBRUVICA™ Approved For Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360®

Mekinist™ (trametinib) & Tafinlar® (dabrafenib) Approved In Combination; Both Limited Distribution Products Immediately Available Via Onco360®

PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform

Results 1 - 6 of 6